3 months evaluation

N = 74

Evaluation after end of adjuvant treatment

N = 74

Statistical significance#

Improvement

Deterioration

Improvement

Deterioration

P value*

No (%)

No (%)

No (%)

No (%)

Breast size

11 (14.9)

3 (4.1)

12 (16.2)

2 (2.7)

0.018

Breast shape

15 (20.3)

3 (4.1)

15 (20.3)

2 (2.7)

0.002

Scar visibility

11 (14.9)

2 (2.7)

10 (13.5)

2 (2.7)

0.021

Nipple position

10 (13.5)

1 (1.35)

10 (13.5)

Zero (0)

0.002

Skin color

5 (6.8)

1 (1.35)

4 (5.4)

Zero (0)

0.046

Donor site

74 (100)

Zero (0)

74 (100)

Zero (0)

<0.001